AIM’s Claire Hannan on Need for Vaccine Funds

AIM’s Claire Hannan on Need for Vaccine Funds

Assessment

Interactive Video

Business, Health Sciences, Social Studies, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The transcript discusses the financial challenges and logistical needs for the COVID-19 vaccination rollout in the U.S. It highlights the funding shortfall faced by states, particularly New York, and the importance of additional federal support. The conversation covers the staffing and logistical challenges in public health agencies, the expected vaccination numbers, and the potential impact of a relief bill. It also touches on the cost efficiency of different vaccines and the role of the private sector in the vaccination process.

Read more

7 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the estimated cost for the entire vaccination campaign?

Less than $500 million

Approximately $1 billion

Over $8 billion

Around $200 million

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the most significant challenge in vaccine distribution according to the transcript?

Lack of vaccine doses

Insufficient staffing

Inadequate storage facilities

Poor public awareness

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many vaccinations did the UK achieve in a week?

300,000

200,000

140,000

100,000

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the expected impact of the relief bill on vaccine distribution funding?

It will increase funding

It will have no impact

It will reduce funding

It will delay funding

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which vaccine requires storage at super low temperatures?

Moderna

AstraZeneca

Pfizer

J&J

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What might affect the overall cost of vaccination?

The number of doses per vaccine

The number of people vaccinated in the private sector

The type of vaccine used

The location of vaccination clinics

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a potential benefit of using the private sector for vaccinations?

It speeds up vaccine approval

It ensures better vaccine storage

It increases vaccine supply

It may reduce costs